Defunct Company
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
180
NCT00026351
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2000
Completion: Jun 30, 2003
NCT00026429
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
Start: Jan 31, 2001
Completion: Not specified
NCT00026442
Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
Start: Nov 30, 2001
NCT00027989
Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
Start: Dec 31, 2001
NCT00131313
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Phase: Phase 4
Role: Collaborator
Start: Jan 31, 2003
Completion: Apr 30, 2009